Tonix Pharma (TNXP) Tops Q4 EPS by 46c

Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($0.56), $0.46 better than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Worthington Industries (WOR) Misses Q4 EPS by 9c
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance